Valuation: Camurus AB

Market Cap 33B 3.39B 2.97B 2.74B 2.56B 4.82B 321B 4.93B 12.74B 158B 12.74B 12.46B 549B P/E 2026 *
36.7x
P/E 2027 * 19.5x
Enterprise Value 28.66B 2.95B 2.58B 2.38B 2.22B 4.19B 279B 4.28B 11.07B 137B 11.07B 10.82B 477B EV / Sales 2026 *
10.2x
EV / Sales 2027 * 6.57x
Free-Float
64.67%
Yield 2026 *
-
Yield 2027 * -
1 day+0.64%
1 week+7.77%
Current month+5.32%
1 month+5.32%
3 months+23.22%
6 months-10.78%
Current year-9.98%
1 week 529.5
Extreme 529.5
565.5
1 month 490
Extreme 490
571
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 268.4
Extreme 268.4
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 2002-12-31
Director of Finance/CFO 57 2025-06-30
Chief Tech/Sci/R&D Officer 58 2024-12-31
Director TitleAgeSince
Director/Board Member 63 2001-12-31
Chairman 77 2014-12-31
Director/Board Member 61 2020-05-06
Date Insider Type Main position Quantity % Market Cap.
Feb. 26Sell

Chief Executive Officer

9,950 0.0166%
Feb. 26Sell

Chief Executive Officer

1,500 0.0025%
Feb. 26Sell

Chief Executive Officer

55,550 0.0928%
Change 5-day change 1-year change 3-year change Capi.($)
+0.64%+7.77%-8.72%+101.34% 3.39B
+1.81%+11.60%+58.61%+164.79% 1,097B
+1.51%+11.77%+69.61%+57.53% 622B
+0.38%+10.56%+39.49%+90.88% 449B
+0.83%+6.34%+29.51%+24.01% 334B
-0.14%+7.58%+39.85%+27.25% 294B
-0.06%+4.92%+31.21%+41.59% 286B
-0.96%+4.98%-28.02%-40.96% 213B
+0.62%+4.59%+30.10%+63.03% 195B
-1.21%+1.17%+14.15%+66.20% 157B
Average +0.19%+6.89%+27.58%+59.57% 365.01B
Weighted average by Cap. +0.64%+8.72%+43.26%+82.07%

Financials

2026 *2027 *
Net sales 2.81B 289M 253M 233M 218M 410M 27.31B 420M 1.08B 13.47B 1.08B 1.06B 46.78B 4.13B 424M 371M 343M 320M 603M 40.1B 616M 1.59B 19.78B 1.59B 1.56B 68.69B
Net income 892M 91.74M 80.33M 74.16M 69.25M 130M 8.67B 133M 345M 4.28B 345M 337M 14.86B 1.68B 172M 151M 139M 130M 245M 16.31B 251M 648M 8.04B 648M 634M 27.93B
Net Debt -4.33B -446M -390M -360M -336M -633M -42.12B -648M -1.67B -20.78B -1.67B -1.64B -72.15B -5.9B -607M -531M -490M -458M -862M -57.35B -882M -2.28B -28.29B -2.28B -2.23B -98.23B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
308
Date Price Change Volume
26-06-30 SEK 560.50 +1.08% 8,936
26-06-29 SEK 554.50 +0.64% 75,799
26-06-26 SEK 551.00 +0.64% 63,071
26-06-25 SEK 547.50 +0.64% 67,130
26-06-24 SEK 544.00 +0.37% 184,495
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
554.50SEK
Average target price
770.75SEK
Spread / Average Target
+39.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock